The Download: the mysteries surrounding weight-loss drugs, and the economic effects of AI

[ad_1]

This is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in the world of technology.

What we still don’t know about weight-loss drugs

Weight-loss drugs have been back in the news this week. First, we heard that Eli Lilly, the company behind Mounjaro and Zepbound, became the first healthcare company in the world to achieve a trillion-dollar valuation.
But we also learned that, disappointingly, GLP-1 drugs don’t seem to help people with…

[ad_2]

Source link